Author:
Corrie Pippa,Meyer Nicolas,Berardi Rossana,Guidoboni Massimo,Schlueter Maximilian,Kolovos Spyros,Macabeo Bérengère,Trouiller Jean-Baptiste,Laramée Philippe
Funder
Les Laboratories Pierre Fabre
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference116 articles.
1. Triple combination therapy with PD-1/PD-L1, BRAF, and MEK inhibitor for stage III–IV melanoma: a systematic review and meta-analysis;Liu Ye;Front. Oncol.,2021
2. Cytologic diagnosis of metastatic melanoma by FNA: a practical review;Ronchi;Cancer Cytopathol,2022
3. Predictive evaluation on cytological sample of metastatic melanoma: the Role of BRAF immunocytochemistry in the molecular era;Ronchi;Diagnostics (Basel),2021
4. Complementarity of clinician judgment and evidence based models in medical decision making: antecedents;Lulin;Prospect Chall Biomed Res Int,2016
5. Crosby TFR, Coles B, Mason M. WITHDRAWN: Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev. 2018;2(2):CD001215.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献